SLDB FY 2024 Earnings — Solid Biosciences Inc. Revenue & Financial Results | Market Cap Arena

SLDBSolid Biosciences Inc.

$644M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$2M

Operating Income

-$130M

Net Income

-$125M

EPS (Diluted)

$-3.06

Cash Flow

Operating Cash Flow

-$100M

Free Cash Flow

-$101M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$189M

Total Liabilities

$51M

Stockholders' Equity

$137M

Cash & Equivalents

$80M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2M	-$3M	+4.9%
Operating Income	-$130M	-$104M	-24.4%
Net Income	-$125M	-$96M	-29.9%